"Flight by machines heavier than air is unpractical and insignificant, if not utterly impossible."
Simon Newcomb, astronomer ; Said in 1902, less than two years before the first flight at Kitty Hawk
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8110218 | Compositions and methods for less immunogenic protein-lipid complexes The present invention provides compositions and methods for reducing the immunogenicity and increasing the circulating half-life of therapeutic proteins such as Factor VIII. The compositions comprise lipidic structures such as liposomes, micelles and cochleates comp... | 02/07/2012 |
| 8110217 | Sphingomyelin liposomes for the treatment of hyperactive bladder disorders The present invention provides pharmaceutical compositions and methods for the instillation of lipid vehicles comprised of liposomes containing sphingomyelin or sphingomyelin metabolites to prevent, manage, ameliorate and/or treat disorders involving neuropathic pai... | 02/07/2012 |
| 8097276 | Method for coating particle with lipid film A method for coating an object, i.e. a particle, with two sheets of lipid film having a space formed there between. In the method for coating a particle having a positive electrostatic-charging property with two sheets of lipid film, the particle having a positive e... | 01/17/2012 |
| 8097277 | Charge-dynamic polymers and delivery of anionic compounds The present invention provides dynamic charge state cationic polymers that are useful for delivery of anionic molecules. The dynamic charge state cationic polymers are designed to have cationic charge densities that decrease by removal of removable functional groups... | 01/17/2012 |
| 8092828 | Fixed drug ratios for treatment of hematopoietic cancers and proliferative disorders Provided herein are methods for treating cancer by administering a pharmaceutical composition comprising a fixed, non-antagonistic molar ratio of cytarabine and an anthracycline. Such methods are particularly useful in the treatment of patients with advanced hematol... | 01/10/2012 |
| 8084057 | Compositions and methods for wound healing The present invention is related to the field of wound healing or tissue regeneration due to disease (i.e., for example, cardiovascular diseases, osteoarthritic diseases, or diabetes). In particular, the present invention provides compositions and methods comprising... | 12/27/2011 |
| 8084056 | Preparation of a lipid blend and a phospholipid suspension containing the lipid blend The present invention describes processes for the preparation of a lipid blend and a uniform filterable phospholipid suspension containing the lipid blend, such suspension being useful as an ultrasound contrast agent. ... | 12/27/2011 |
| 8080262 | Encapsulated peptide amphiphile nanostructures The present invention provides compositions and methods for creating encapsulated peptide amphiphilic nanostructures useful in treating diseases. In particular, the present invention provides compositions and methods for preparing peptide amphiphile nanostructures t... | 12/20/2011 |
| 8075913 | Method of producing a cationic liposomal preparation comprising a lipophilic compound A method for producing a cationic liposomal preparation comprising a lipophilic active compound with physical and chemical stability during manufacturing, storing and reconstituting, and further a cationic liposomal preparation obtainable by this method as well as s... | 12/13/2011 |
| 8071127 | Dual action, inhaled formulations providing both an immediate and sustained release profile Methods for formulating immediate and sustained release anti-infectives and delivery of such for treatment of respiratory tract infections and other medical conditions, and devices and formulations used in connection with such are described. ... | 12/06/2011 |
| 8062663 | Methods and compostions for enhancing transdermal drug delivery Methods and compositions for enhancing transdermal delivery of a bioactive agent. The method contains the step of applying to a skin tissue an effective amount of a composition comprising: (a) a drug vehicle; (b) a bioactive agent encapsulated within the drug vehicl... | 11/22/2011 |
| 8062662 | Liposomes containing an entrapped compound in supersaturated solution A liposome composition having a compound entrapped in a supersaturated solution and method for preparing such a composition are described. ... | 11/22/2011 |
| 8058254 | DNA vaccines encoding heat shock proteins The present invention is related to a method of treating a T cell-mediated inflammatory autoimmune disease by administering to an individual in need thereof an immunogenic composition comprising a recombinant construct of a nucleic acid sequence encoding heat shock ... | 11/15/2011 |
| 8048448 | Nanoshells for drug delivery Nano-constructs comprising nanoshells and methods of using the nano-constructs for treating or ameliorating a medical condition are provided. ... | 11/01/2011 |
| 8034375 | Combinations and modes of administration of therapeutic agents and combination therapy The present invention provides combination therapy methods of treating proliferative diseases (such as cancer) comprising a first therapy comprising administering to an individual an effective amount of a taxane in a nanoparticle composition, and a second therapy wh... | 10/11/2011 |
| 8034376 | Lipid containing formulations Compositions and methods useful in administering nucleic acid based therapies, for example association complexes such as liposomes and lipoplexes are described. ... | 10/11/2011 |
| 8021686 | Lipid-encapsulated polyanionic nucleic acid Methods for the preparation of a lipid-nucleic acid composition are provided. According to the methods, a mixture of lipids containing a protonatable or deprotonatable lipid, for example an amino lipid and a lipid such as a PEG- or Polyamide oligomer-modified lipid ... | 09/20/2011 |
| 8017147 | Nutritional supplement for the prevention of cardiovascular disease, alzheimer's disease, diabetes, and regulation and reduction of blood sugar and insulin resistance A synergistic mixture (which may be utilized as a food or a drink or a supplement or a drug or a cosmetic or a hygienic product) that is formulated and is capable of improving a person's well being, lowering the risks of cardiovascular and/or Alzheimer's diseases an... | 09/13/2011 |
| 7993672 | Stable lipid-comprising drug delivery complexes and methods for their production Novel stable, concentrated, biologically active and ready-to-use lipid-comprising drug delivery complexes and methods for their production are described. The biological activity of the complexes produced are comparable to the formulations prepared according to the p... | 08/09/2011 |
| 7985417 | Method of lipid structure preparation A method of inserting a lipid-linked moiety into a lipid assembly, such as a planar lipid monolayer or bilayer, a spherical lipid vesicle, a micelle, or an emulsion envelope monolayer is described. In the method, the lipid assembly and the lipid-linked moiety are co... | 07/26/2011 |
| 7981442 | Ultrasound enhancement of drug release across non-ionic surfactant membranes A method of targeted drug delivery and imaging using nonionic surfactant vesicles (niosomes) in combination with ultrasound. Niosomes have potential applications in targeted drug delivery and imaging because of their ability to encapsulate therapeutic agents and the... | 07/19/2011 |
| 7976868 | Liposomes comprising duramycin and anti-viral agents Disclosed are surprising discoveries concerning the role of anionic phospholipids and aminophospholipids in tumor vasculature and in viral entry and spread, and compositions and methods for utilizing these findings in the treatment of cancer and viral infections. Al... | 07/12/2011 |
| 7968115 | Liposomal curcumin for treatment of cancer The present invention provides a compositions and methods for the treatment of cancer, including pancreatic cancer, breast cancer and melanoma, in a human patient. The methods and compositions of the present invention employ curcumin or a curcumin analogue encapsula... | 06/28/2011 |
| 7968116 | Antitumor agent A sugar-cholestanol compound which can be readily synthesized and which exhibits a satisfactory antitumor activity. An anticancer agent containing, as an active ingredient, a cholestanol compound represented by the following formula (1): | 06/28/2011 |
| 7968117 | Externally triggered microcapsules Disclosed are microcapsules comprising a polymer shell enclosing one or more immiscible liquid phases in which a drug or drug precursor are contained in a liquid phase. The microparticles also contain magnetic particles that can be heated by application of an extern... | 06/28/2011 |
| 7964214 | Method and composition for hyperthermally treating cells in the eye with simultaneous imaging A method and composition for hyperthermally treating cells in the eye with simultaneous imaging. The heat (temperature) production inside the eye (target) tissue is imaged. The desired temperature is achieved using a laser and photoacoustic imaging technique. Hypert... | 06/21/2011 |
| 7955618 | Composition for treatment of inflammatory disorders A pharmaceutical composition for parenteral administration, comprising liposomes composed of non-charged vesicle-forming lipids, including up to 20 mole percent of an amphipathic vesicle-forming lipid derivatized with polyethyleneglycol, and optionally including not... | 06/07/2011 |
| 7951396 | Preparation of nanoliposome-encapsulating proteins and protein-encapsulated nanoliposome Preparing a nanoliposome for encapsulating a protein includes preparing a dispersion by dispersing a phospholipid in an aqueous solution containing the protein, applying a shearing force to the dispersion; adding an additional amount of the phospholipid to the resul... | 05/31/2011 |
| 7927622 | Methods of transnasal transport/immunization with highly adaptable carriers The invention deals with the transport of preferably large molecules across nasal mucosa by means of specially designed, highly adaptable carriers loaded with said molecules. One of the purposes of making such formulations is to achieve non-invasive systemic deliver... | 04/19/2011 |
| 7919113 | Dispersible concentrate lipospheres for delivery of active agents A formulation containing one or more lipophilic agents, methods of making and using the formulation are described herein. The formulation is formed by adding a pre-suspension concentrate composition to an aqueous medium. Upon contact with the aqueous medium, a solid... | 04/05/2011 |
| 7914814 | Topical delivery of arginine of cause beneficial effects A preparation is disclosed for producing enhanced blood flow in tissue thus causing beneficial effects such as promoting hair growth on scalp tissue lacking sufficient hair, restoring normal sexual function in males with erectile dysfunction. Specifically, this is a... | 03/29/2011 |
| 7914815 | Method for delivery of pharmaceuticals for treating or preventing presbyopia Embodiments of the present invention relate to a method for delivering pharmaceuticals to the lens of the eye to treat or prevent presbyopia. According to the embodiments, pharmaceuticals may be applied by providing the pharmaceuticals to the eye and promoting deliv... | 03/29/2011 |
| 7906139 | Compositions and methods of using lamellar bodies for therapeutic purposes Compositions comprising lamellar bodies for removal of extra and intra-vascular fibrin for therapeutic purposes are disclosed. These lamellar compositions are also useful in surgical procedures wherein formation of post-surgical adhesions are likely. Methods of prev... | 03/15/2011 |
| 7906140 | Compositions for mucosal delivery of agents Compositions and methods for mucosal delivery of agents are provided. The compositions are intended for administration to mucosal surface, such as oral and nasal mucosa. The compositions provided contain one or more mucoadhesive proteins and an agent to be delivered... | 03/15/2011 |
| 7901708 | Liposomal apparatus and manufacturing methods The present invention provides apparatus and processes for producing liposomes. By providing a buffer solution in a first reservoir, and a lipid solution in a second reservoir, continuously diluting the lipid solution with the buffer solution in a mixing chamber pro... | 03/08/2011 |
| 7901709 | Temperature-sensitive liposomal formulation A liposome contains an active agent and has a gel-phase lipid bilayer membrane comprising phospholipid and a surface active agent. The phospholipids are the primary lipid source for the lipid bilayer membrane and the surface active agent is contained in the bilayer ... | 03/08/2011 |
| 7887836 | Compositions and methods for treating lymphoma This invention provides methods for treating neoplasias in a mammal. In particular, the invention provides methods for treating various types of lymphomas, including relapsed forms of non-Hodgkin's Lymphoma. These methods involve the administration of liposome-encap... | 02/15/2011 |
| 7887833 | Amphiphilic compounds and vesicles liposomes for organ-specified drug targeting An amphiphilic compound is provided capable of forming vesicles or liposomes, said amphiphilic compound having at least one headgroup containing a selectively cleavable group or moiety such as a residue of a choline or phenylalanine derivative, and at least one hydr... | 02/15/2011 |
| 7887834 | Aqueous dispersions of silicone polyether block copolymers Aqueous dispersions of (AB)n silicone polyether block copolymers, methods for preparing the dispersion compositions, and personal, household, and healthcare formulations containing the compositions are disclosed. The aqueous dispersions can be either vesi... | 02/15/2011 |
| 7887835 | Compound comprising a fluorine-substituted alkyl group and a liposome contrast medium comprising the compound A steroid ester compound of a terminally-fluorinated alkyl fatty acid, a steroid compound having bis(trifluoromethyl)phenyl group, a phosphatidylserine compound having a terminally-fluorinated alkyl group, a glyceride compound having bis(trifluoromethyl phenyl group... | 02/15/2011 |